Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Characterizing Oncogenic Fusions and Biological Condensates using Proximity Proteomics
FY 2022-23
Summary
Outline of Proposed Research: Cellular response to extracellular signals is an integral part of homeostasis. The activation of signaling pathways is largely controlled by kinases which are tightly regulated in cells as their constitutive activation may lead to tumorigenesis by promoting sustained proliferation. Genomic instability, which can lead to translocations, is a hallmark of cancer. This aberrant process can lead to the generation of chimeric proteins through the fusion of two genes (oncogenic fusions). Oncogenic fusions with an active kinase domain (e.g. EML4-ALK and CCDC6-RET) can drive cancer progression by forming biological condensates via liquid-liquid phase separation (LLPS)4. However, much is unknown at the molecular level. BioID is a proximity-dependent biotinylation approach that can be used along with mass spectrometry to identify proteins surrounding a protein of interest in phase-separated biological condensates.
Aim 1: With BioID, I will determine proteins that are aberrantly recruited to the oncogenic fusions EML4-ALK and CCDC6-RET. Further, each parent gene will be analysed separately to determine the proteins that interact uniquely with the oncogenic fusions.
Aim 2: The phosphorylation of proteins can be a good indicator of specific pathway activation. I will purify and analyze phosphopeptides to identify signaling pathways that are activated by EML4-ALK and CCDC6-RET. Moreover, BioID will be combined to phosphopeptide enrichment to identify phosphorylated proteins located in oncogenic LLPS condensates.
Significance: This unbiased proteomics approach will allow us to identify components that are recruited to oncogenic condensates and pathways activated by kinase fusions, leading to the identification of potential novel targets for therapies.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486576
Name
Cheng Jayco
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterizing Oncogenic Fusions and Biological Condensates using Proximity Proteomics
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioid; Biological Condensates; Cancer; Cell Signalling Pathways; Gene Fusion; Liquid Liquid Phase Separation; Mass Spectrometry; Oncogenic Fusions; Proximity Proteomics; Targeted Treatment
Abstract
Outline of Proposed Research: Cellular response to extracellular signals is an integral part of homeostasis. The activation of signaling pathways is largely controlled by kinases which are tightly regulated in cells as their constitutive activation may lead to tumorigenesis by promoting sustained proliferation. Genomic instability, which can lead to translocations, is a hallmark of cancer. This aberrant process can lead to the generation of chimeric proteins through the fusion of two genes (oncogenic fusions). Oncogenic fusions with an active kinase domain (e.g. EML4-ALK and CCDC6-RET) can drive cancer progression by forming biological condensates via liquid-liquid phase separation (LLPS)4. However, much is unknown at the molecular level. BioID is a proximity-dependent biotinylation approach that can be used along with mass spectrometry to identify proteins surrounding a protein of interest in phase-separated biological condensates.
Aim 1: With BioID, I will determine proteins that are aberrantly recruited to the oncogenic fusions EML4-ALK and CCDC6-RET. Further, each parent gene will be analysed separately to determine the proteins that interact uniquely with the oncogenic fusions.
Aim 2: The phosphorylation of proteins can be a good indicator of specific pathway activation. I will purify and analyze phosphopeptides to identify signaling pathways that are activated by EML4-ALK and CCDC6-RET. Moreover, BioID will be combined to phosphopeptide enrichment to identify phosphorylated proteins located in oncogenic LLPS condensates.
Significance: This unbiased proteomics approach will allow us to identify components that are recruited to oncogenic condensates and pathways activated by kinase fusions, leading to the identification of potential novel targets for therapies.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cheng, Jayco
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~